Brain tumor diagnostic on MR
Stroke Detection on CT
2D and 4D Flow in Brain MRI
All the tools you need to diagnose and follow up brain tumors
IB Neuro non-invasively distinguishes tumor from PTRE with >95% accuracy. IB DeltaT1 allows rapid and objective identification of TRUE enhancing regions. IB Diffusion calculates (ADC) maps, and other diffusion parameters such as Intra Voxel Inherent Motion (IVIM), Extrapolated b-value, and stretched exponential (Alpha diffusion and DDC) IB DCE for Automated generation of perfusion parameter maps (Ktrans, Vp, T10, Initial Slope, Time to Peak, Peak Enhancement, initial area under curve).
AI solution for neurovascular emergencies
Using a combination of deep learning and machine learning technologies, CINA Head automatically detects and prioritizes acute ICH and LVO cases within 20 seconds, seamlessly alerting the radiologist within their existing systems and workflow.
Visualize and quantify flow precisely in the intracranial vessels
Leverage Arterys Flow post-processing to visualize and quantify flow measurements in the carotids and large brain vessels and support your research projects aiming to study blood flow in aneurysms and stenosis or in pediatric patients.
*4DFlow for intracranial vessels is used for Research use only in US
Arteys Neuro AI product includes a brain oncology processing suite powered by Imaging Biometrics and a stroke detection software powered by Avicenna.AI.
**Imaging Biometrics for neuro-oncology**
Despite its widespread use, MRI-DSC imaging has been plagued by inconsistent and suboptimal ways of acquiring and processing DSC-MRI data resulting in mixed opinions regarding its usefulness. Instead, IB Neuro has been honed and developed, over two decades, to account for subtle nuances in data acquisition and post-processing. It is the only MRI-DSC platform that offers truly quantitative output regardless of scanner platform, field strength, or time point and is the only commercial platform validated with tissue biopsy samples by multiple institutions.
Imaging Biometrics algorithms are the only commercially available tissue validated rCBV method that answers the most important question in neuro oncology today:
“Is the enhancing region showing tumor or is it an effect due to treatment?”
**Avicenna.AI for Stroke detection**
Stroke is a leading cause of death in the US, with more than 795,000 strokes resulting in more than 100,000 deaths each year. It is estimated that up to a third of the most common type of stroke are caused by LVO, when a clot blocks the circulation of the blood in the brain. Around 1 in 10 strokes are thought to be caused by ICH, or bleeding that occurs inside the skull. Using a combination of deep learning and machine learning technologies, CINA® Head automatically detects and prioritizes acute ICH and LVO cases within 20 seconds, seamlessly alerting the radiologist within their existing systems and workflow.
CINA’s ICH detection capability was validated using data from 814 cases conducted at more than 250 imaging centers across the United States, with 96% accuracy, 91.4% sensitivity and 97.5% specificity. The product’s LVO detection capability was validated based on 476 cases, with 97.7% accuracy 97.9% sensitivity and 97.6% specificity.
The Arterys software is a medical diagnostic application that displays, processes, stores, and transfers DICOM and non-DICOM medical data. It is intended to be used as a support tool by trained healthcare professionals to aid in diagnosis. It is intended to provide image and related information that is interpreted by a trained professional to render findings and/or diagnosis, but it does not directly generate any diagnosis or potential findings.
Model performance metrics
Refer to publications linked on the page.